Viewing Study NCT00243204


Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-01-05 @ 5:09 PM
Study NCT ID: NCT00243204
Status: TERMINATED
Last Update Posted: 2007-06-08
First Post: 2005-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
Sponsor: Point Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module